Form 8-K - Current report:
SEC Accession No. 0001193125-24-255269
Filing Date
2024-11-12
Accepted
2024-11-12 09:20:29
Documents
16
Period of Report
2024-11-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d867502d8k.htm   iXBRL 8-K 28271
2 EX-5.1 d867502dex51.htm EX-5.1 14180
6 GRAPHIC g867502g1109053704776.jpg GRAPHIC 5840
7 GRAPHIC g867502g1109053705091.jpg GRAPHIC 1579
  Complete submission text file 0001193125-24-255269.txt   180547

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dyn-20241112.xsd EX-101.SCH 2849
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dyn-20241112_lab.xml EX-101.LAB 17980
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dyn-20241112_pre.xml EX-101.PRE 11259
18 EXTRACTED XBRL INSTANCE DOCUMENT d867502d8k_htm.xml XML 3627
Mailing Address 1560 TRAPELO ROAD WALTHAM MA 02451
Business Address 1560 TRAPELO ROAD WALTHAM MA 02451 (781) 786-8230
Dyne Therapeutics, Inc. (Filer) CIK: 0001818794 (see all company filings)

EIN.: 364883909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39509 | Film No.: 241444098
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)